{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:04Z","timestamp":1747181104425,"version":"3.40.5"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,20]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">Tripterygium wilfordii<\/jats:italic> hook (TWH) has been used to treat Behcet\u2019s disease (BD) but its underlying mechanism remains unclear. This study aims to explore the mechanism of TWH on BD using network pharmacology and molecular docking. The bioactive constituents of TWH and their corresponding target genes were extracted from the Traditional Chinese Medicine systems pharmacology database and analysis platform. BD target genes were obtained by searching the DisGeNet and GeneCards databases. Gene ontology annotation and Kyoto encyclopedia of genes and genomes pathway enrichment analysis were conducted to elucidate the function of overlapping genes between TWH and BD target genes. A protein-protein interaction network was constructed using Cytoscape and STRING platforms, and the core target genes were identified from the overlapping genes. Finally, molecular docking was used to assess the binding affinity between the core targets and TWH bioactive constituents. We identified 25 intersection genes related to both TWH and BD and 27 bioactive ingredients of TWH. Through analysis of protein-protein interaction network, 6 core targets (TNF, IFNG, prostaglandin-endoperoxide synthase 2, NOS2, VCAM-1, and interleukin-2) were screened out. Enrichment analysis demonstrated that the antioxidant properties of TWH constituents might play a significant role in their therapeutic effects. Molecular docking revealed high binding affinity between the bioactive constituents of TWH, such as kaempferol, triptolide, 5, 8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin, and their corresponding target genes, suggesting the potential of TWH to treat BD. Our investigation clarified the active components, therapeutic targets of BD in the treatment of TWH and provided a theoretical foundation for further researches.<\/jats:p>","DOI":"10.1097\/md.0000000000034512","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T15:23:30Z","timestamp":1697815410000},"page":"e34512","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the pharmacological mechanism of Tripterygium wilfordii hook for treatment of Behcet\u2019s disease using network pharmacology and molecular docking"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4255-017X","authenticated-orcid":false,"given":"Lihua","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Dermatology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Hainan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changrong","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Cosmetology Clinic, Hainan Yilimei Medical Cosmetology Co., Hainan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Hainan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WeiHong","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Hainan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Hainan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Hainan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Behcet syndrome: a contemporary view.","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet\u2019s disease.","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","article-title":"Relationships of HLA-B51 or B5 genotype with Behcet\u2019s disease clinical characteristics: systematic review and meta-analyses of observational studies.","volume":"51","author":"Maldini","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Behcet\u2019s disease.","volume":"10","author":"Tong","year":"2019","journal-title":"Front Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"624795","DOI":"10.3389\/fmed.2021.624795","article-title":"Treatment of Behcet\u2019s disease: an algorithmic multidisciplinary approach.","volume":"8","author":"Alpsoy","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2040622314523062","article-title":"Update on the therapy of Behcet disease.","volume":"5","author":"Saleh","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-017-0681-6","article-title":"An update on the use of biologic therapies in the management of uveitis in Behcet\u2019s disease: a comprehensive review.","volume":"12","author":"McNally","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"8202512","DOI":"10.1155\/2021\/8202512","article-title":"Effectiveness and safety of Chinese medicine decoctions for Behcet\u2019s disease: a systematic review and meta-analysis.","volume":"2021","author":"Yan","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/nu13010046","article-title":"Herbal medicine for Behcet\u2019s disease: a systematic review and meta-analysis.","volume":"13","author":"Jun","year":"2020","journal-title":"Nutrients"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2018.00356","article-title":"The effectiveness and safety of Tripterygium wilfordii hook F extracts in rheumatoid arthritis: a systematic review and meta-analysis.","volume":"9","author":"Zhou","year":"2018","journal-title":"Front Pharmacol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ptr.5987","article-title":"Efficacy and safety of Tripterygium wilfordii hook F for CKD in Mainland China: a systematic review and meta-analysis.","volume":"32","author":"Wang","year":"2018","journal-title":"Phytother Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MPG.0000000000002218","article-title":"Complementary and alternative medicine use in children with inflammatory bowel disease.","volume":"68","author":"Phatak","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R13-20250504","first-page":"1","article-title":"Long-term efficacy of Tripterygium hypoglaucum hutch in treating patients with Behcet disease-associated uveitis.","volume":"6","author":"Qiao","year":"2021","journal-title":"Japanese J Gstro Hepato"},{"key":"R14-20250504","first-page":"598","article-title":"Effect of Tripterygium glycosides on serum interleukin-1beta, interleukin-2, tumor necrosis factor alpha, and interferon-gamma levels in patients with Behcet\u2019s disease.","volume":"30","author":"Song","year":"2010","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"R16-20250504","first-page":"94","article-title":"Detection and impact of the vascular endothelial function of Behcet\u2019s disease by Tripterygium Wilfordii.","volume":"2","author":"Yang","year":"2016","journal-title":"Chin J Dermatovenereol Integr"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2019.00123","article-title":"Network pharmacology databases for traditional Chinese medicine: review and assessment.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Pharmacol"},{"key":"R18-20250504","first-page":"652373","article-title":"A network study of Chinese medicine xuesaitong injection to elucidate a complex mode of action with multicompound, multitarget, and multipathway.","volume":"2013","author":"Wang","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"138460","DOI":"10.1155\/2014\/138460","article-title":"Network pharmacology in traditional Chinese medicine.","volume":"2014","author":"Li","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"690118","DOI":"10.3389\/fphar.2021.690118","article-title":"Identification of tumor necrosis factor-alpha (TNF-alpha) inhibitor in rheumatoid arthritis using network pharmacology and molecular docking.","volume":"12","author":"Bai","year":"2021","journal-title":"Front Pharmacol"},{"issue":"Suppl 4","key":"R22-20250504","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome.","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","article-title":"a web server for cavity detection-guided protein-ligand blind docking.","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"713052","DOI":"10.3389\/fmed.2021.713052","article-title":"Pathogenesis of Behcet\u2019s syndrome: genetic, environmental and immunological factors.","volume":"8","author":"Mattioli","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1631\/jzus.B1900607","article-title":"Use of Tripterygium wilfordii hook F for immune-mediated inflammatory diseases: progress and future prospects.","volume":"21","author":"Song","year":"2020","journal-title":"J Zhejiang Univ Sci B"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"5276865","DOI":"10.1155\/2019\/5276865","article-title":"A network pharmacology study on the active ingredients and potential targets of Tripterygium wilfordii hook for treatment of rheumatoid arthritis.","volume":"2019","author":"Hu","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/07853890.2021.1918345","article-title":"Multi-target mechanism of Tripteryguim wilfordii hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking.","volume":"53","author":"Zhang","year":"2021","journal-title":"Ann Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet\u2019s disease.","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.3390\/ijms21093072","article-title":"Beh\u04abet\u2019s disease, and the role of TNF-alpha and TNF-alpha blockers.","volume":"21","author":"van der Houwen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-kappaB by TNF family cytokines.","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin Immunol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3892\/etm.2017.4749","article-title":"Triptolide inhibits the function of TNF-alpha in osteoblast differentiation by inhibiting the NF-kappaB signaling pathway.","volume":"14","author":"Liu","year":"2017","journal-title":"Exp Ther Med"},{"key":"R32-20250504","first-page":"2731","article-title":"Mechanism of triptolide in treating ankylosing spondylitis through the anti-ossification effect of the BMP\/Smad signaling pathway.","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/ar290","article-title":"The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1\/Th2 paradigm in autoimmunity.","volume":"3","author":"Theofilopoulos","year":"2001","journal-title":"Arthritis Res"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09273948.2012.671882","article-title":"T cells activation and interferon-gamma\/nitric oxide production during Behcet disease: a study in Algerian patients.","volume":"20","author":"Djaballah-Ider","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1346-8138.1998.tb02446.x","article-title":"The levels of plasma interleukin-2 and soluble interleukin-2R in Behcet\u2019s disease: a marker of disease activity.","volume":"25","author":"Alpsoy","year":"1998","journal-title":"J Dermatol"},{"key":"R36-20250504","first-page":"996","article-title":"Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet\u2019s disease.","volume":"39","author":"Sugi-Ikai","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R37-20250504","first-page":"S28","article-title":"Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet\u2019s disease.","volume":"29","author":"Shahram","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ptr.3471","article-title":"Triptolide inhibits IFN-gamma signaling via the Jak\/STAT pathway in HaCaT keratinocytes.","volume":"25","author":"Hongqin","year":"2011","journal-title":"Phytother Res"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1099-1573(199909)13:6<464::AID-PTR483>3.0.CO;2-4","article-title":"Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506.","volume":"13","author":"Chan","year":"1999","journal-title":"Phytother Res"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1073\/pnas.1517642113","article-title":"Systematic study of constitutive cyclooxygenase-2 expression: role of NF-kappaB and NFAT transcriptional pathways.","volume":"113","author":"Kirkby","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/14756366.2011.572281","article-title":"Oxidases and oxygenases in regulation of neutrophil redox pathways in Behcet\u2019s disease patients.","volume":"27","author":"Melikoglu","year":"2012","journal-title":"J Enzyme Inhib Med Chem"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ptr.3538","article-title":"Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and MAP kinases in lipopolysaccharide-treated PC12 cells.","volume":"26","author":"Geng","year":"2012","journal-title":"Phytother Res"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ijms19041057","article-title":"Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer.","volume":"19","author":"Kong","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0035-1556727","article-title":"Endothelial dysfunction and altered coagulation as mediators of thromboembolism in Behcet disease.","volume":"41","author":"Butta","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jir.2018.0116","article-title":"Role of serum miR-181b, proinflammatory cytokine, and adhesion molecules in Behcet\u2019s disease.","volume":"39","author":"El Boghdady","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"R46-20250504","first-page":"1958","article-title":"Kaempferol inhibits multiple pathways involved in the secretion of inflammatory mediators from LPS-induced rat intestinal microvascular endothelial cells.","volume":"19","author":"Bian","year":"2019","journal-title":"Mol Med Rep"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury.","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"590622","DOI":"10.3389\/fimmu.2020.590622","article-title":"Neutrophil extracellular traps promote aberrant macrophages activation in Behcet\u2019s disease.","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1468-3083.2005.01075.x","article-title":"Evaluation of nitrosative and oxidative stress in Behcet disease.","volume":"19","author":"Bekpinar","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"e0153289","DOI":"10.1371\/journal.pone.0153289","article-title":"Investigating the role of TNF-alpha and IFN-gamma activation on the dynamics of iNOS gene expression in LPS stimulated macrophages.","volume":"11","author":"Salim","year":"2016","journal-title":"PLoS One"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1620\/tjem.197.9","article-title":"Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behcet\u2019s disease.","volume":"197","author":"Kose","year":"2002","journal-title":"Tohoku J Exp Med"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fcvm.2019.00089","article-title":"Reactive oxygen species (ROS), intimal thickening, and subclinical atherosclerotic disease.","volume":"6","author":"Burtenshaw","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.semarthrit.2015.06.018","article-title":"Subclinical atherosclerosis in Behcet\u2019s disease: a systematic review and meta-analysis.","volume":"45","author":"Merashli","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R54-20250504","first-page":"502","article-title":"Effects of polyglycosides of Tripterygium wilfordii hook on inflammation and immune suppression.","volume":"6","author":"Li","year":"2000","journal-title":"J Shanghai Med Univ"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13510002.2021.2004047","article-title":"The antioxidant effect of triptolide contributes to the therapy in a collagen-induced arthritis rat model.","volume":"26","author":"Yu","year":"2021","journal-title":"Redox Rep"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/10715769900300841","article-title":"Antioxidant defence mechanisms: from the beginning to the end (of the beginning).","volume":"31","author":"Halliwell","year":"1999","journal-title":"Free Radic Res"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00204-007-0215-4","article-title":"Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF-16 in the model organism Caenorhabditis elegans.","volume":"81","author":"Kampkotter","year":"2007","journal-title":"Arch Toxicol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:33:07Z","timestamp":1746325987000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":56,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034512","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,10,20]]}}}